2023 annual financial data
InMed Pharmaceuticals 2023 Net margin
Direct answer
Net margin was -192.18%.
Operating income was -8,378,787 CAD and net income was -7,947,622 CAD.
Operating cash flow was -7,283,199 CAD.
Get free InMed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,135,561 CAD
- Operating income
- -8,378,787 CAD
- Net income
- -7,947,622 CAD
- Operating cash flow
- -7,283,199 CAD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all InMed Pharmaceuticals financial years